U.S. Physical Therapy, Inc.
NYSE:USPHMedical - Care Facilities
+$0.12 today
- Market cap
- $1.42B
- Beta
- 1.16
- P/E (TTM)
- 810.7
- EPS (TTM)
- $0.08
- Dividend yield
- 2.89%
Volume 0.33M
Average 0.20M
USPH Deferred Tax Liabilities
Taxes owed in future periods because of timing differences between accounting and tax rules.
U.S. Physical Therapy, Inc.NYSE: USPH
Deferred Tax Liabilities · Q1 FY2026 · quarter ended Mar 2026
Deferred tax liabilities falls 9.6% from a year ago
Deferred tax liabilities stood at $30.78M at the end of Q1 FY2026, down 9.6% from a year earlier and up 8.4% from the prior quarter. Over 3 fiscal years it compounded at +10.0% a year.
Context
- Deferred tax liabilities amounted to 2.5% of total assets at the end of Q1 FY2026, down 0.4 pp from a year earlier.
- Deferred tax liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether deferred tax liabilities keeps falling in the next quarterly balance sheet after a -9.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Tax Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 28.39M USD
- Year-over-year change
- -3.6%
- 4-year CAGR
- +18.5%
| Period | Period end | Deferred Tax Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 28.39M | -3.6% |
| FY2024 | 2024-12-31 | 29.47M | +18.7% |
| FY2023 | 2023-12-31 | 24.82M | +16.5% |
| FY2022 | 2022-12-31 | 21.3M | +48.1% |
| FY2021 | 2021-12-31 | 14.39M | — |
Deferred Tax Liabilities vs competitors
How USPH compares with its peers on the latest reported figures
- USPH's Mar 2026 deferred tax liabilities of $30.78M is the 4th highest of the 11 companies compared; the peer median is $658.5K.
- Its year-over-year change of -9.6% is the 5th highest of 6, against a peer median of +16.3%.
- Deferred tax liabilities amounts to 2.5% of total assets for USPH, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Aug 2026 | $251.4M | -9.3% | -10.0% | 7.6% | |
| Mar 2026 | $117.86M | +56.6% | -12.9% | 2.0% | |
| Mar 2026 | $81.38M | +16.3% | +6.0% | 3.5% | |
| Mar 2026 | $30.78M | -9.6% | +10.0% | 2.5% | |
| Mar 2026 | $7.4M | +76.3% | -27.2% | 0.3% | |
| Mar 2026 | $1.32M | -52.6% | — | 0.1% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Jan 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | +24.2% | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Apr 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding USPH) | $658.5K | +16.3% | -10.0% | 0.1% | |
Competitors are the stored peer set for USPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 28.57M | 31.59M | 152.83M | 41.36M | 35.57M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 62.42M | 69.31M | 69.72M | 85.67M | 88.34M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 4.18M | 10.37M | 10.83M | 10.56M | 16.08M |
| Total Current Assets | 95.17M | 111.27M | 233.38M | 137.58M | 139.99M |
| Property, Plant & Equipment (Net) | 119.41M | 127.75M | 129.53M | 166.08M | 271.07M |
| Goodwill | 434.68M | 494.1M | 509.57M | 667.15M | 692.39M |
| Intangible Assets | 86.38M | 108.76M | 109.68M | 179.31M | 172.86M |
| Long-term Investments | 12.22M | 12.13M | 12.26M | 12.19M | 12.28M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.58M | 4.15M | 2.82M | 5.16M | (84.58M) |
| Total Non-current Assets | 654.26M | 746.89M | 763.86M | 1.03B | 1.06B |
| Total Assets | 749.43M | 858.15M | 997.24M | 1.17B | 1.2B |
| Account Payables | 6.47M | 6.5M | 3.9M | 5.94M | 6.06M |
| Short-term Debt | 830K | 7.86M | 7.69M | 11M | 52M |
| Tax Payables | 2.72M | 277K | 1.36M | 4.92M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 22.49M | 0 | 80.98M |
| Total Current Liabilities | 83.48M | 85.49M | 102.19M | 116.28M | 139.04M |
| Long-term Debt | 117.59M | 175.83M | 138.99M | 142.53M | 263.17M |
| Deferred Tax Liabilities | 14.39M | 21.3M | 24.82M | 29.47M | 28.39M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 7.35M | 13.03M | 2.36M | 18.28M | (107.36M) |
| Total Non-current Liabilities | 213.5M | 288.1M | 242.82M | 292.14M | 294.77M |
| Total Liabilities | 296.98M | 373.59M | 345M | 408.42M | 433.81M |
| Common Stock | 151K | 152K | 172K | 172K | 174K |
| Retained Earnings | 224.4M | 232.95M | 223.77M | 227.27M | 227.22M |
| Accumulated OCI | (0) | 4M | 2.78M | 2.8M | 714K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 156.84M | 168.78M | 176.04M | 270.12M | 293.31M |
| Total Equity | 452.44M | 484.57M | 652.24M | 759.05M | 769.74M |
| Total Debt | 223.08M | 295.34M | 258.59M | 295.23M | 425.74M |
| Net Debt | 194.51M | 263.74M | 105.76M | 253.87M | 390.17M |
U.S. Physical Therapy, Inc.
NYSE:USPH
Intrinsic Alpha fair value
Locked
Current Price
$95.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.